Latitude Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
AIM
SLAM
CWP
Latitude Advisors's PFE Position: Q2 2026 in Review
Latitude Advisors reduced its Pfizer (PFE) stake by 6.8% in Q2 2026, selling an estimated $20.7K and leaving 10,916 shares worth $263K. The position accounts for 0.1% of the portfolio, ranked #210.
Latitude Advisors first reported a position in PFE in Q1 2021 and has held it in 22 quarters since. The position peaked at $1.67M in Q1 2022. 1,259 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Latitude Advisors held 10,916 shares of Pfizer worth $263K as of Q2 2026.
- Latitude Advisors sold 792 Pfizer shares in Q2 2026, an estimated $20.7K.
- Pfizer made up 0.1% of Latitude Advisors's portfolio in Q2 2026, its #210 holding.
- Latitude Advisors first reported a position in Pfizer in Q1 2021 and has held it in 22 quarters since.
- Latitude Advisors's Pfizer position peaked at $1.67M in Q1 2022.
- 1,259 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Latitude Advisors's 13F filing for Q2 2026, filed 28 Jul 2026.